FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

771451006: Platelet aggregation inhibitor (disposition)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3706255019 Platelet aggregation inhibitor (disposition) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3706256018 Platelet aggregation inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Platelet aggregation inhibitor Is a Disposition true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Substance with platelet aggregation inhibitor mechanism of action (substance) Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Abciximab Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Prasugrel hydrochloride Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Prasugrel Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Clopidogrel besilate Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Clopidogrel bisulfate Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Clopidogrel hydrochloride Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Clopidogrel Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Eptifibatide Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Dipyridamole Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Ticlopidine hydrochloride Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Ticlopidine Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Ticagrelor Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Selexipag Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Caplacizumab Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Milrinone lactate Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Milrinone Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Aloxiprin Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Aluminium aspirin Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Vorapaxar Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Triflusal Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Treprostinil sodium Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Treprostinil Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Tirofiban hydrochloride monohydrate Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Tirofiban Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Cangrelor Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Cilostazol Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Iloprost Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Indobufen Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Buffered aspirin Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Aspirin Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Aspirin DL-lysine Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Resveratrol Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Calcium carbaspirin Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Epoprostenol sodium Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Epoprostenol Has disposition True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Prasugrel besilate Has disposition False Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
P2Y12 G-protein-coupled platelet receptor antagonist Is a True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier
Platelet glycoprotein-IIb/IIIa receptor antagonist Is a True Platelet aggregation inhibitor Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start